1,660 results on '"Schiano, Thomas"'
Search Results
2. A Prospective Open-Label Dose–Response Study to Correct Vitamin D Deficiency in Cirrhosis
3. Obliterative Portal Venopathy
4. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation
5. Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy
6. Banff 2022 Liver Group Meeting report: Monitoring long-term allograft health
7. Four-Year-History of Recurrent Fever, Skin Lesions, and Liver Abscesses in a Patient with Common Variable Immune Deficiency due to Helicobacter cinaedi Infection
8. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series
9. Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problem
10. Evolution of intestinal and multivisceral transplantation: A thirty-year United States perspective
11. Summary of a consensus conference on heart-liver transplantation
12. The Varying Histology of Hepatic Sarcoidosis and the Relation of Bile Duct Damage and Loss to the Presence of Portal Hypertension and Cirrhosis
13. Serum and tissue biomarkers of plasma cell-rich rejection in liver transplant recipients
14. Modeling spreading with degassing using anisotherm viscoplastic multiphase shallow water approximation
15. Systemic Disease and the Liver Part 2: Pregnancy-Related Liver Injury, Sepsis/Critical Illness, Hypoxia, Psoriasis, Scleroderma/Sjogren's Syndrome, Sarcoidosis, Common Variable Immune Deficiency, Cystic Fibrosis, Inflammatory Bowel Disease, and Hematologic Disorders
16. Systemic Disease and the Liver-Part 1: Systemic Lupus Erythematosus, Celiac Disease, Rheumatoid Arthritis, and COVID-19
17. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension
18. A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
19. The Importance of Segment 4 Anatomy on Outcomes Following Living Donor Left Lateral Segmentectomy
20. Performance of native and gadoxetate-enhanced liver and spleen T1 mapping for noninvasive diagnosis of clinically significant portal hypertension: preliminary results
21. A viscoplastic approach to corium spreading during a severe nuclear accident
22. A Review of the Clinical Presentation, Outcomes, and Treatments of Patients Having Desmoid Tumors
23. SAT-021 Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival in an international multicentre cohort
24. Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma
25. Outcomes of Anesthesiologist-Led Care of Patients Following Liver Transplantation During the COVID-19 Pandemic
26. Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis
27. Two hundred and fifty-one right hepatectomies for living donation: Association between preoperative risk factors, hepatic dysfunction, and complications
28. 4D flow MRI in abdominal vessels: prospective comparison of k-t accelerated free breathing acquisition to standard respiratory navigator gated acquisition
29. Single‐cell RNA sequencing data identify a conserved population of metallothionein‐expressing macrophages that may be ubiquitous in vital human organs.
30. Obliterative Portal Venopathy during Estrogen Therapy in a Transgender Woman: A Case Report.
31. Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation.
32. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis
33. A comparative study of cirrhosis sub-staging using the Laennec system, Beijing classification, and morphometry
34. DCD Hepatitis C Virus–positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized
35. The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change
36. Transforming global hepatology training: a call for action
37. MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center
38. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis
39. Inpatient Specialty-Level Palliative Care Is Delivered Late in the Course of Hepatocellular Carcinoma and Associated With Lower Hazard of Hospital Readmission
40. The role of endoscopy in the small intestinal transplant recipient: A review
41. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma
42. Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery
43. Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen
44. Fatal cerebral edema in patients with decompensated cirrhosis: A case series
45. Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection
46. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C−positive Donors in the United States: An Analysis of the OPTN/UNOS Database
47. Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs.
48. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation
49. Acute Liver Failure Secondary to Drug-Induced Liver Injury
50. Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.